Korsana Biosciences, Inc. (KRSA)
NASDAQ: KRSA · Real-Time Price · USD
31.11
-0.06 (-0.19%)
Nov 10, 2026, 4:00 PM EST - Market closed
Korsana Biosciences Market Cap
Korsana Biosciences has a market cap or net worth of $1.42 billion as of November 10, 2026. It is the 8,221st most valuable company in the world and the 2,007th biggest in the United States. Its market cap has increased by 27,168.20% in one year.
Market Cap
1.42B
Enterprise Value
1.28B
1-Year Change
27,168.20%
Global Rank
Country Rank
#2,007 United States
Category
ChartMarket Cap Chart
Since March 18, 2019, Korsana Biosciences's market cap has increased from $193.31M to $1.42B, an increase of 632.93%. That is a compound annual growth rate of 29.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 1.42B | 29,209.63% |
| Dec 31, 2025 | 4.83M | -40.68% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nuvation Bio | 1.47B |
| Damora Therapeutics | 1.47B |
| Tyra Biosciences | 1.45B |
| Kardigan | 1.45B |
| Structure Therapeutics | 1.45B |
| Rapport Therapeutics | 1.45B |
| Ocular Therapeutix | 1.45B |
| Taysha Gene Therapies | 1.41B |